Literature DB >> 8502538

Which is the most appropriate dosage of liposomal Amphotericin-B (AmBisome) for the treatment of fungal infections in infants of very low birth weight?

L P da Silva, J M Amaral, N C Ferreira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8502538

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  5 in total

Review 1.  Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.

Authors:  A J Coukell; R N Brogden
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

Review 2.  Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review.

Authors:  J Evdoridou; E Roilides; E Bibashi; G Kremenopoulos
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

3.  Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome).

Authors:  J H Weitkamp; C F Poets; R Sievers; E Musswessels; P Groneck; P Thomas; P Bartmann
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

Review 4.  Antifungals in systemic neonatal candidiasis.

Authors:  Daniel A C Frattarelli; Michael D Reed; George P Giacoia; Jacob V Aranda
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Systemic fungal infections in neonates.

Authors:  P C Ng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.